Progression of continuous downstream processing of monoclonal antibodies: Current trends and challenges
暂无分享,去创建一个
Kristina Pleitt | Balaji Somasundaram | Evan Shave | Kym Baker | Linda H L Lua | L. Lua | Kym Baker | E. Shave | Balaji Somasundaram | Kristina Pleitt
[1] P. Alves,et al. Improved virus purification processes for vaccines and gene therapy , 2015, Biotechnology and bioengineering.
[2] L. Connell‐Crowley,et al. Cation exchange chromatography provides effective retrovirus clearance for antibody purification processes , 2012, Biotechnology and bioengineering.
[3] Dimitrios I. Gerogiorgis,et al. Economic Analysis of Integrated Continuous and Batch Pharmaceutical Manufacturing: A Case Study , 2011 .
[4] N Avdalovic,et al. Protein variant separations by cation-exchange chromatography on tentacle-type polymeric stationary phases. , 1998, Journal of chromatography. A.
[5] J. Pezzini,et al. Accelerated , Seamless Antibody Purification Process Intensification with Continuous Disposable Technology , 2016 .
[6] Hadi Parastar,et al. Multivariate Curve Resolution Methods for Qualitative and Quantitative Analysis in Analytical Chemistry , 2015 .
[7] Kate Zhang,et al. Identification and quantitation of vesivirus 2117 particles in bioreactor fluids from infected Chinese hamster ovary cell cultures , 2013, Biotechnology and bioengineering.
[8] M. Schofield,et al. Transfer of a three step mAb chromatography process from batch to continuous: Optimizing productivity to minimize consumable requirements. , 2017, Journal of biotechnology.
[9] Duncan Low,et al. Future of antibody purification. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[10] Alois Jungbauer,et al. Protein Chromatography: Process Development and Scale-Up , 2010 .
[11] Marc Bisschops,et al. Continuous Chromatography Is Now Possible for Clinical Manufacturing , 2016 .
[12] Marc Bisschops,et al. The impact of continuous multicolumn chromatography on biomanufacturing efficiency , 2013 .
[13] P. He,et al. Temperature effect on peak width and column efficiency in subcritical water chromatography. , 2002, Journal of chromatographic science.
[14] L. Castilho,et al. Development of a 3‐step straight‐through purification strategy combining membrane adsorbers and resins , 2017, Biotechnology progress.
[15] William G. Whitford,et al. Single‐Use Systems Support Continuous Bioprocessing by Perfusion Culture , 2014 .
[16] L. Lerner,et al. A rapid method for determining dynamic binding capacity of resins for the purification of proteins. , 2008, Protein expression and purification.
[17] Suzanne S Farid,et al. Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture , 2017, Biotechnology progress.
[18] Anurag S Rathore,et al. Comparison of different options for harvest of a therapeutic protein product from high cell density yeast fermentation broth , 2006, Biotechnology and bioengineering.
[19] R L Fahrner,et al. Membrane ion-exchange chromatography for process-scale antibody purification. , 2001, Journal of chromatography. A.
[20] J. Stickel,et al. Pressure‐Flow Relationships for Packed Beds of Compressible Chromatography Media at Laboratory and Production Scale , 2001, Biotechnology progress.
[21] S. Hober,et al. Protein A chromatography for antibody purification. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[22] Marcelo Fernández-Lahore,et al. Chromatographic Characterization and Process Performance of Column-Packed Anion Exchange Fibrous Adsorbents for High Throughput and High Capacity Bioseparations , 2015 .
[23] C. I. Collins,et al. Peak shape analysis and plate theory for plasma chromatography , 1975 .
[24] Gerhard Schembecker,et al. Developing the biofacility of the future based on continuous processing and single-use technology. , 2015, Journal of biotechnology.
[25] Suzanne S. Farid,et al. Integrated economic and experimental framework for screening of primary recovery technologies for high cell density CHO cultures , 2016, Biotechnology journal.
[26] Massimo Morbidelli,et al. Design and operation of a continuous integrated monoclonal antibody production process , 2017, Biotechnology progress.
[27] J. Coffman,et al. A tandem laboratory scale protein purification process using Protein A affinity and anion exchange chromatography operated in a weak partitioning mode , 2013, Biotechnology and bioengineering.
[28] Uwe Gottschalk,et al. Bioseparation in Antibody Manufacturing: The Good, The Bad and The Ugly , 2008, Biotechnology progress.
[29] R. Million,et al. Monoclonal antibody biosimilars , 2015, Nature Reviews Drug Discovery.
[30] Konstantin B Konstantinov,et al. The future of industrial bioprocessing: batch or continuous? , 2015, Biotechnology and bioengineering.
[31] Oliver Kaltenbrunner,et al. Continuous bind‐and‐elute protein A capture chromatography: Optimization under process scale column constraints and comparison to batch operation , 2016, Biotechnology progress.
[32] Mark Pagkaliwangan,et al. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales , 2019, Biotechnology journal.
[33] W. Berthold,et al. Interaction of cell culture with downstream purification: a case study , 2004, Cytotechnology.
[34] Mark Schofield,et al. Implementation of an end-to-end continuous bioprocessing platform using novel technologies , 2017 .
[35] Iain Beattie,et al. Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. , 2004, Rapid communications in mass spectrometry : RCM.
[36] Frank Riske,et al. Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins. , 2012, Biotechnology journal.
[37] R. Bayer,et al. Recovery and purification process development for monoclonal antibody production , 2010, mAbs.
[38] Jason Walther,et al. The business impact of an integrated continuous biomanufacturing platform for recombinant protein production. , 2015, Journal of biotechnology.
[39] Christopher Miller,et al. High‐throughput miniaturized bioreactors for cell culture process development: Reproducibility, scalability, and control , 2014, Biotechnology progress.
[40] Ye Zhang,et al. Very High Density of CHO Cells in Perfusion by ATF or TFF in WAVE Bioreactor™. Part I. Effect of the Cell Density on the Process , 2013, Biotechnology progress.
[41] Ich Topic Q5A. GUIDANCE FOR INDUSTRY Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin , 2001 .
[42] Bharat Reddy,et al. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1 , 2004, Nature Network Boston.
[43] Sarah A Johnson,et al. Adapting viral safety assurance strategies to continuous processing of biological products , 2017, Biotechnology and bioengineering.
[44] Roger Brunkow,et al. The clarification of bioreactor cell cultures for biopharmaceuticals , 2003 .
[45] Gerhard Schembecker,et al. Cost evaluation of antibody production processes in different operation modes , 2016 .
[46] L. Richard Stock,et al. The Potential Impact of Continuous Processing on the Practice and Economics of Biopharmaceutical Manufacturing , 2014 .
[47] Kurt Brorson,et al. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals. , 2005, Current opinion in biotechnology.
[48] Kurt Brorson,et al. Impact of multiple re-use of anion-exchange chromatography media on virus removal. , 2005, Journal of chromatography. A.
[49] E. Boschetti,et al. Composite affinity sorbents and their cleaning in place. , 1990, Journal of chromatography.
[50] Günter Jagschies,et al. Continuous Capture of mAbs—Points to Consider and Case Studies , 2018 .
[51] Daniel Cummings,et al. Integrated continuous production of recombinant therapeutic proteins , 2012, Biotechnology and bioengineering.
[52] Ekta Mahajan,et al. Improving affinity chromatography resin efficiency using semi-continuous chromatography. , 2012, Journal of chromatography. A.
[53] Tim Tressel,et al. Current Therapeutic Antibody Production and Process Optimization , 2006 .
[54] Qualification of a chromatographic column: Why and how to do it , 2003 .
[55] Eric Langer,et al. Continuous Bioprocessing and Perfusion: Wider Adoption Coming as Bioprocessing Matures , 2014 .
[56] R. Kunert,et al. Advances in recombinant antibody manufacturing , 2016, Applied Microbiology and Biotechnology.
[57] Christian Hakemeyer,et al. Complete clarification solution for processing high density cell culture harvests , 2015 .
[58] Priyabrata Pattnaik,et al. Packing of large-scale chromatography columns with irregularly shaped glass based resins using a stop-flow method , 2014, Biotechnology progress.
[59] Jennifer Halley,et al. Protein A chromatography increases monoclonal antibody aggregation rate during subsequent low pH virus inactivation hold , 2015, Journal of chromatography. A.
[60] A. Shukla,et al. Evolving trends in mAb production processes , 2017, Bioengineering & translational medicine.
[61] Brian Hubbard,et al. Downstream processing of monoclonal antibodies--application of platform approaches. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[62] Daniel G Bracewell,et al. Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture. , 2013, Journal of chromatography. A.
[63] Alois Jungbauer,et al. Continuous cell flocculation for recombinant antibody harvesting , 2017, Journal of chemical technology and biotechnology.
[64] Gail Sofer,et al. Process Validation in Manufacturing of Biopharmaceuticals , 2012 .
[65] Jing Liu,et al. A mechanistic study of Protein A chromatography resin lifetime. , 2009, Journal of chromatography. A.
[66] Paul J. Mcdonald,et al. Fragments of protein A eluted during protein A affinity chromatography. , 2007, Journal of chromatography. A.
[67] Joanna Rucker-Pezzini,et al. Single Pass Diafiltration Integrated into a Fully Continuous mAb Purification Process. , 2018, Biotechnology and bioengineering.
[68] C. Lindsley. New 2016 Data and Statistics for Global Pharmaceutical Products and Projections through 2017. , 2017, ACS chemical neuroscience.
[69] D. Cecchini,et al. Inactivation of viruses using novel protein A wash buffers , 2015, Biotechnology progress.
[70] Bernhardt L Trout,et al. Regulatory Perspectives on Continuous Pharmaceutical Manufacturing: Moving From Theory to Practice: September 26-27, 2016, International Symposium on the Continuous Manufacturing of Pharmaceuticals. , 2017, Journal of pharmaceutical sciences.
[71] D. Walls,et al. Protein Chromatography , 2017, Methods in Molecular Biology.
[72] Andrew L. Zydney,et al. Perspectives on integrated continuous bioprocessing — opportunities and challenges , 2015 .
[73] Nigel J. Titchener-Hooker,et al. Evaluation of a structural mechanics model to predict the effect of inserts in the bed support of chromatographic columns , 2013 .
[74] G. Schembecker,et al. Continuous viral inactivation at low pH value in antibody manufacturing , 2016 .
[75] Konstantin Konstantinov,et al. End-to-end integrated fully continuous production of recombinant monoclonal antibodies. , 2015, Journal of biotechnology.
[76] C. Jungreuthmayer,et al. Trend analysis of performance parameters of pre-packed columns for protein chromatography over a time span of ten years. , 2016, Journal of chromatography. A.
[77] M Vanderlaan,et al. Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes , 2001, Biotechnology & genetic engineering reviews.
[78] Andrew L. Zydney,et al. Continuous downstream processing for high value biological products: A Review , 2016, Biotechnology and bioengineering.
[79] Karan Sukhija,et al. A Single-use Strategy to Enable Manufacturing of Affordable Biologics , 2016, Computational and structural biotechnology journal.
[80] Alois Jungbauer,et al. Comparison of protein A affinity sorbents II. Mass transfer properties. , 2005, Journal of chromatography. A.
[81] S. Lute,et al. Analysis of viral clearance unit operations for monoclonal antibodies , 2010, Biotechnology and bioengineering.
[82] P. Duncan,et al. Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products. , 2014, Vaccine.
[83] D. Ecker,et al. The therapeutic monoclonal antibody market , 2015, mAbs.
[84] Feng Li,et al. Cell culture processes for monoclonal antibody production , 2010, mAbs.
[85] Suzanne S Farid,et al. Process economics of industrial monoclonal antibody manufacture. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[86] Yao-ming Huang,et al. Perfusion seed cultures improve biopharmaceutical fed‐batch production capacity and product quality , 2014, Biotechnology progress.
[87] Alois Jungbauer,et al. Comparison of protein A affinity sorbents. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.